Vimarsana
Biggest News Aggregation in the World

Page 12 - Caredx Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caredx Inc Today - Breaking & Trending Today

CareDx, Inc (NASDAQ:CDNA) Receives $13.60 Consensus Target Price from Brokerages - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Receives $13.60 Consensus Target Price from Brokerages

CareDx, Inc (NASDAQ:CDNA – Get Free Report) has been assigned an average rating of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month target price among […]

Source: wkrb13.com
CareDx, Inc (NASDAQ:CDNA) Given Consensus Recommendation of "Hold" by Brokerages - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Given Consensus Recommendation of "Hold" by Brokerages

Shares of CareDx, Inc (NASDAQ:CDNA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six research firms that are currently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price […]

CareDx To Present at the 2023 Cantor Global Healthcare Conference - Vimarsana News

CareDx To Present at the 2023 Cantor Global Healthcare Conference

CareDx, Inc. , a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

10x Genomics and Stanford's Genomic Patents Determined Patent Eligible - Vimarsana News

10x Genomics and Stanford's Genomic Patents Determined Patent Eligible

On Sept. 14, 2023, the U.S. District Court for the District of Delaware denied defendant Parse Biosciences Inc.’s (Parse) motion to dismiss a…

10x Genomics and Stanford's Genomic Patents Determined Patent Eligible | Kramer Levin Naftalis & Frankel LLP - Vimarsana News

10x Genomics and Stanford's Genomic Patents Determined Patent Eligible | Kramer Levin Naftalis & Frankel LLP

On Sept. 14, 2023, the U.S. District Court for the District of Delaware denied defendant Parse Biosciences Inc.’s (Parse) motion to dismiss a complaint filed by plaintiffs 10x Genomics...